New pill for daytime sleepiness enters human testing
NCT ID NCT07082829
First seen Jan 11, 2026 · Last updated Jun 17, 2026 · Updated 33 times
Summary
This early-stage trial tests an experimental drug called ORX142 in healthy adults and older adults to see if it is safe and how the body processes it. The study also checks how the drug works in people who have been kept awake overnight. The goal is to gather initial safety and dosing information for a potential treatment for excessive daytime sleepiness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EXCESSIVE DAYTIME SLEEPINESS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Site #1
RECRUITINGLincoln, Nebraska, 68502, United States
-
Site #2
RECRUITINGEatontown, New Jersey, 07724, United States
-
Site #3
RECRUITINGNew York, New York, 10019, United States
Conditions
Explore the condition pages connected to this study.